Skip to main content
. 2022 Aug 17;16:896172. doi: 10.3389/fncel.2022.896172

TABLE 3.

mRNA expression of GFAP, TNF-α, AQP4, and Kir4.1 in cerebral cortex of control and TAA-treated groups.

Group I
(The control group)
Group II
(TAA-treated group)
GFAP gene expression (2–ΔΔCT) 1 ± 0.02 1.91 ± 0.16*
TNF-α gene expression (2–ΔΔCT) 1 ± 0.02 2.12 ± 0.13*
AQP4 gene expression (2–ΔΔCT) 1 ± 0.03 2.41 ± 0.11*
Kir4.1 gene expression (2–ΔΔCT) 1 ± 0.03 0.61 ± 0.04*

*Significant compared to control group.